ROK
48
4
VFC
38
-9
PFG
37
3
MLM
72
2
VMC
62
2
RRC
45
-5
GME
60
-7
DG
32
6
SO
66
-2
DVN
18
-2
ROST
75
3
BEN
36
2
MU
50
3
JPM
59
3
SRCL
70
12
STI
34
-14
LMT
37
-2
MMC
67
2
AFL
57
2
HAL
29
3
ROK
48
4
VFC
38
-9
PFG
37
3
MLM
72
2
VMC
62
2
RRC
45
-5
GME
60
-7
DG
32
6
SO
66
-2
DVN
18
-2
ROST
75
3
BEN
36
2
MU
50
3
JPM
59
3
SRCL
70
12
STI
34
-14
LMT
37
-2
MMC
67
2
AFL
57
2
HAL
29
3
Financhill
Back

Epiroc AB Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
36

EPIAF
Epiroc AB

Last Price:
19.59
Seasonality Move:
-0.96%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
36
Epiroc AB (EPIAF) is a Sell

Is Epiroc AB a Buy, Sell or Hold?

  • The current Epiroc AB [EPIAF] share price is $19.59. The Score for EPIAF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • EPIAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EPIAF Stock Price Chart

What is Epiroc AB's stock price today?

  • The Epiroc AB share price today is $19.59
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EPIAF is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

EPIAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 44.12 Sell
Chaikin Money Flow: -3356 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.17 - 21.37) Sell
Bollinger Bands (100): (18.24 - 20.5) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

EPIAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.48 Sell
20-day SMA: 20.87 Sell
50-day SMA: 20.08 Sell
200-day SMA: 18.98 Buy
8-day EMA: 20.46 Sell
20-day EMA: 20.55 Sell
50-day EMA: 20.17 Sell
200-day EMA: 19.3 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Epiroc AB Earnings Growth & EPIAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Epiroc AB Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):